Revium Rx (RVRC) Cash & Current Investments (2024 - 2025)
Revium Rx (RVRC) reported Cash & Current Investments of $2.7 million for Q4 2025, down 48.65% on a YoY basis from $5.3 million in Q4 2024, and down 48.65% sequentially from $5.3 million in Q4 2024.
Revium Rx (RVRC) Cash & Current Investments (2024 - 2025) Analysis & Trends
Revium Rx (RVRC) has 2 years of Cash & Current Investments data on file, last reported at $2.7 million in Q4 2025.
- For the quarter ending Q4 2025, Cash & Current Investments fell 48.65% year-over-year to $2.7 million; the trailing twelve-month figure through Dec 2025 stood at $2.7 million (down 48.65% YoY), and the FY2025 full-year result was $2.7 million, down 48.65% from the prior year.
- Cash & Current Investments declined to $2.7 million in Q4 2025, from $5.3 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $5.3 million in Q4 2024 to a low of $2.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.81 Bn | 24.49 Bn | 662.02 Mn | 7.31 Bn |
| 2 | BrightSpring Health Services | 14.76 Bn | 13.86 Bn | 482.22 Mn | 901.03 Mn |
| 3 | Healthequity | 8.36 Bn | 8.10 Bn | 256.31 Mn | 265.37 Mn |
| 4 | Hinge Health | 5.91 Bn | 5.60 Bn | 154.23 Mn | 315.87 Mn |
| 5 | 10x Genomics | 5.89 Bn | 5.35 Bn | 106.18 Mn | 539.85 Mn |
| 6 | MiniMed | 4.45 Bn | 4.16 Bn | 480.00 Mn | 298.00 Mn |
| 7 | Waystar Holding | 4.41 Bn | 4.35 Bn | 216.84 Mn | 62.70 Mn |
| 8 | Doximity | 3.93 Bn | 3.18 Bn | 125.97 Mn | 748.60 Mn |
| 9 | Privia Health | 3.10 Bn | 2.68 Bn | - | 419.52 Mn |
| 10 | Revium Rx | 101.42 Mn | 98.71 Mn | - | 2.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.71 Mn |
| Dec 31, 2024 | 5.28 Mn |